Comparative evaluation of the safety and efficacy of recombinant FVIII in severe hemophilia A patients-Reference-Cited by-同舟云学术

Comparative evaluation of the safety and efficacy of recombinant FVIII in severe hemophilia A patients

Published:2018-06-30 Issue:2 Volume:21 Page:76-81
ISSN:2093-6966
Container-title:Journal of Pharmacopuncture
language:en
Short-container-title:J Pharmacopuncture

Author:

Abolghasemi Hassan¹,Panahi Yunes²,Ahmadinejad Minoo³,Toogeh Gholamreza,Karimi Mehran⁴,Eghbali Aziz⁵,Mirbehbahani Nargess Bigom⁶,Dehdezi Bighan Keikhaei⁷,Badiee Zahra⁸,Hoorfar Hamid⁹,Eshghi Peyman¹,Maghsoudi Nader¹⁰,Sahebkar Amirhossein¹¹¹²¹³,Gholami-Fesharaki Mohammad¹⁴

Affiliation:

1. Pediatric Congenital Hematologic Disorders Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran

2. Pharmacotherapy Department, Faculty of Pharmacy, Baqiyatallah University of Medical Sciences, Tehran, Iran

3. High Institute of Research, Iranian Blood Transfusion Organization, Tehran, Iran

4. Hematology Research Centre, Shiraz University of Medical Sciences, Shiraz, Iran

5. Department of Pediatric Hematology-Oncology, Mofid Children’s Hospital, Shahid Beheshti University of Medical Sciences, Tehran, Iran

6. Golestan University of Medical Sciences, Gorgan, Iran

7. Department of Thalassemia & Hemoglobinopathy Research Center, Ahvaz Jundishapur University of Medical Science, Ahvaz, Iran

8. Doctor Sheikh Hospital, Mashhad University of Medical Sciences, Mashhad, Iran

9. Isfahan University of Medical Sciences, Isfahan, Iran

10. Neuroscience Research Center (NRC), Shahid Beheshti University of Medical Sciences, Tehran, Iran

11. Biotechnology Research Center, Pharmaceutical Technology Institute, Mashhad University of Medical Sciences, Mashhad, Iran

12. Neurogenic Inflammation Research Center, Mashhad University of Medical Sciences, Mashhad, Iran

13. School of Pharmacy, Mashhad University of Medical Sciences, Mashhad, Iran

14. Department of Biostatistics, Faculty of Medical Sciences, Tarbiat Modares University, Tehran, Iran

Publisher

Korean Pharmacopuncture Institute

Subject

Complementary and alternative medicine,Pharmacology

Link

http://pdf.medrang.co.kr/JOP/2018/021/2093-6966-v21-n02-076.pdf

Reference23 articles.

1. The Hemophilias — From Royal Genes to Gene Therapy

2. Definitions in Hemophilia

3. Cost effectiveness of Iran national plasma contract fractionation program

4. Faranoush M. Patients Perspective in Plasma Products (Focus on Hemophilia). Iranian Journal of Blood and Cancer 2011;3:171-5.

5. Economical impact of plasma fractionation project in Iran on affordability of plasma-derived medicines

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. An overview of the current status of follow-on biologicals in Iran;Generics and Biosimilars Initiative Journal;2021-06-15

2. Haemophiliac adolescents’ perspectives of resilience: A qualitative study based on the resilience in illness model;Clinical Child Psychology and Psychiatry;2019-12-08